Related Experiment Video
Updated: May 19, 2026
05:46
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
Antiretroviral dynamics determines HIV evolution and predicts therapy outcome
Daniel I S Rosenbloom1, Alison L Hill, S Alireza Rabi
1Department of Mathematics, Harvard University, Cambridge, Massachusetts, USA.
Nature Medicine
|September 4, 2012
Summary
Mathematical modeling reveals how adherence to HIV drugs impacts treatment success and resistance. Certain combination therapies may prevent resistance irrespective of patient adherence, guiding future HIV treatment strategies.
Area of Science:
- Virology
- Pharmacology
- Mathematical Biology
Background:
- Current anti-HIV therapies achieve high viral replication inhibition but treatment failure and drug resistance remain significant clinical challenges.
- The relationship between patient adherence and the emergence of drug-resistant HIV strains varies considerably across different drug classes.
- Understanding the factors driving treatment failure and resistance is crucial for optimizing HIV management.
Purpose of the Study:
- To develop a mathematical model explaining the observed differences in resistance emergence based on drug class and patient adherence.
- To predict treatment outcomes and identify strategies for preventing drug resistance in HIV patients.
- To provide a framework for simulating clinical trials of novel anti-HIV regimens.
Main Methods:
- Development of a mathematical model incorporating drug properties (e.g., dose-response curves, half-life), fitness differences between susceptible and resistant viral strains, mutation dynamics, and patient adherence.
- Simulation of viral dynamics under various drug regimens and adherence levels.
- Analysis of model predictions against clinical observations.
Main Results:
- Antiviral activity declines rapidly for drugs with sharp dose-response curves and short half-lives (e.g., boosted protease inhibitors), shortening the window for resistance selection.
- Poor adherence to these specific drugs can lead to treatment failure through the proliferation of susceptible virus, reconciling puzzling clinical observations.
- The model predicts that specific single-pill combination therapies can effectively prevent HIV drug resistance, even with imperfect patient adherence.
Conclusions:
- The developed mathematical model successfully explains clinical observations regarding adherence and HIV drug resistance.
- Certain combination antiretroviral therapies hold promise for preventing resistance development, irrespective of patient adherence.
- This modeling approach offers a valuable tool for guiding the development and selection of future anti-HIV treatment strategies and clinical trials.
More Related Videos
Related Concept Videos
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
01:26Size and Structure of Viral Genomes
Viral genomes exhibit remarkable diversity in size, structure, and composition, influencing their replication strategies and interactions with host cells. These genomes consist of either DNA or RNA and may be linear or circular. Additionally, they can be single-stranded or double-stranded, with each configuration affecting how the virus propagates within a host. RNA viruses, for instance, generally have smaller genomes than DNA viruses, a factor that contributes to their high mutation rates and...
00:36Viral Mutations
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material for adaptive...
02:33Retroviruses
Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.